HYDROCODONE Drug Patent Profile

When do Hydrocodone patents expire, and what generic alternatives are available?

Hydrocodone is a drug marketed by Nostrum Labs Inc, Alvogen, Mallinckrodt, Mikart, Chartwell, Genus, Mallinckrodt Inc, Nesher Pharms, Pharm Assoc, Tris Pharma Inc, Vintage Pharms, Wes Pharma Inc, Abhai Llc, Able, Actavis Labs Fl Inc, Amneal Pharms, Amneal Pharms Ny, Apil, Ascent Pharms Inc, Aurolife Pharma Llc, Barr, Caraco, Cerovene Inc, Epic Pharma Llc, Granules, Halsey, Ivax Pharms, Lannett Co Inc, Mutual Pharm, Novel Labs Inc, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Rhodes Pharms, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Ucb Inc, Upsher Smith Labs, Usl Pharma, Vintage Pharms Llc, Watson Labs, Watson Labs Florida, Lgm Pharma, Acella, Actavis Mid Atlantic, Apozeal Pharms, Ivax Sub Teva Pharms, Padagis Us, Wockhardt Bio Ag, Ani Pharms, Teva, Mayne Pharma Inc, and Neos Theraps Inc. and is included in one hundred and fifty-seven NDAs.

The generic ingredient in HYDROCODONE is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.

Summary for HYDROCODONE

US Patents:	0
Applicants:	56
NDAs:	157
Raw Ingredient (Bulk) Api Vendors:	19
Clinical Trials:	135
Patent Applications:	4,888
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for HYDROCODONE
Drug Sales Revenues:	Drug sales revenues for HYDROCODONE
DailyMed Link:	HYDROCODONE at DailyMed

See drug prices for HYDROCODONE

See drug sales revenues for HYDROCODONE

Recent Clinical Trials for HYDROCODONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medpace, Inc.	Phase 1
Ohio Third Frontier	Phase 1
Charles River Labs	Phase 1

See all HYDROCODONE clinical trials

US Patents and Regulatory Information for HYDROCODONE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Ny	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	040754-001	Aug 25, 2006		DISCN	No	No
Wes Pharma Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	210211-003	Oct 30, 2017	AA	RX	No	No
Cerovene Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	211690-001	Feb 7, 2020		DISCN	No	No
Actavis Labs Fl Inc	HYDROCODONE BITARTRATE AND IBUPROFEN	hydrocodone bitartrate; ibuprofen	TABLET;ORAL	076604-001	Dec 31, 2003	AB	RX	No	No
Abhai Llc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	209036-003	Jun 21, 2017	AA	RX	No	No
Pharm Assoc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	SOLUTION;ORAL	040838-001	May 10, 2013	AA	RX	No	No